Clinical trialNCT04789616UnknownPhase 2Interventional

The Canadian Maraviroc Randomized Controlled Trial To Augment Rehabilitation Outcomes After Stroke

SponsorUniversity of CalgaryEnrollment120Stroke

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The CAMAROS trial is a randomized controlled phase II trial analyzing the effect of coupling a C-C chemokine receptor 5 (CCR5) antagonist, Maraviroc (Celsentri), and exercise to improve both upper and lower extremity recovery after a stroke.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Bruce Dobkin, MD
University of California, Los Angeles, California, USA
Study Chair
clinicaltrials.gov ↗
Sean Dukelow, MD PhD FRCPC
University of Calgary
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada

University of Calgary & Foothills Medical Centre
Calgary, Alberta, Canada
Gentson Leung, MD
Recruiting
University of British Columbia & Gf Strong Rehabilitation Centre
Vancouver, British Columbia, Canada
Courtney Pollock, PhDJanice Eng, PhDJennifer Yao, MD
Recruiting
Dalhousie University
Halifax, Nova Scotia, Canada
Anita Mountain, MDMarilyn Mackay-Lyons, PhD
Recruiting
Parkwood Institute
London, Ontario, Canada
Robert Teasell, MD
Recruiting
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada
Bradley MacIntosh, PhDSandra Black, MD
Not, yet, recruiting
Toronto Rehabilitation Institute - University Health Network
Toronto, Ontario, Canada
Mark Bayley, MD
Not, yet, recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Maraviroc →

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 15 Sept 2022
Primary completion: 31 Dec 2025
Completion: 31 Dec 2025
Last update posted: 9 Jul 2024
Registered enrollment: 120
Registry id: NCT04789616

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.